Trials / Completed
CompletedNCT06917040
Enhancing Protection Against Vector-borne Diseases in Forcibly Displaced Communities: Evaluating the Efficacy of Spatial Repellents for Cutaneous Leishmaniasis Control in North-East Syria
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 18,404 (actual)
- Sponsor
- The Mentor Initiative · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The aim of this study is to determine the efficacy of Mosquito Shield (spatial repellent) in reducing cutaneous leishmaniasis case incidence among internally displaced persons and sandfly density in temporary shelters and camp settings in Ar-Raqqa governorate, North-East Syria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Spatial repellant emanator | Spatial emanator with an active ingredient Transfluthrin (C15H12Cl2F4O2, 110mg, EPA registered number 432-1588). |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2022-04-01
- Completion
- 2022-04-01
- First posted
- 2025-04-08
- Last updated
- 2025-04-08
Locations
1 site across 1 country: Syria
Source: ClinicalTrials.gov record NCT06917040. Inclusion in this directory is not an endorsement.